Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis

被引：38

作者：

Cherifi, S

Robberecht, J

Miendje, Y

机构：

[1] Free Univ Brussels, Brugmann Hosp, Dept Internal Med, B-1050 Brussels, Belgium

[2] Free Univ Brussels, Brugmann Hosp, Dept Microbiol, Brussels, Belgium

来源：

ACTA CLINICA BELGICA | 2004年 / 59卷 / 04期

关键词：

Sacharomyces cerevisiae; Clostridium difficile colitis;

D O I：

10.1179/acb.2004.033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Saccharomyces boulardii is widely used as a probiotic compound and is generally thought to be safe. We report one case of fungemia caused by Saccharomyces cerevisiae occurring in an elderly patient treated orally with S. boulardii in association with vancomycin for Clostridium difficile colitis. We do not recommend administering this viable yeast particularly in debilited patient with active colitis.

引用

收藏

页码：223 / 224

页数：2

相关论文

共 8 条

[1] Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii [J].

Bassetti, S ;

Frei, R ;

Zimmerli, W .

AMERICAN JOURNAL OF MEDICINE, 1998, 105 (01) :71-72

[2] Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis [J].

D'Souza, AL ;

Rajkumar, C ;

Cooke, J ;

Bulpitt, CJ .

BRITISH MEDICAL JOURNAL, 2002, 324 (7350) :1361-1364

[3] Saccharomyces boulardii fungemia in a patient receiving ultra-levure therapy [J].

Fredenucci, I ;

Chomarat, M ;

Boucaud, C ;

Flandrois, JP .

CLINICAL INFECTIOUS DISEASES, 1998, 27 (01) :222-223

[4] Seven cases of fungemia with Saccharomyces boulardii in critically ill patients [J].

Lherm, T ;

Monet, C ;

Nougière, B ;

Soulier, M ;

Larbi, D ;

Le Gall, C ;

Caen, D ;

Malbrunot, C .

INTENSIVE CARE MEDICINE, 2002, 28 (06) :797-801

[5] Clustering of Saccharomyces boulardii strains within the species S-cerevisiae using molecular typing techniques [J].

Mitterdorfer, G ;

Mayer, HK ;

Kneifel, W ;

Viernstein, H .

JOURNAL OF APPLIED MICROBIOLOGY, 2002, 93 (04) :521-530

[6] Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a nonimmunocompromised host [J].

Rijnders, BJA ;

Van Wijngaerden, E ;

Verwaest, C ;

Peetermans, WE .

INTENSIVE CARE MEDICINE, 2000, 26 (06) :825-825

[7] Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients [J].

Riquelme, AJ ;

Calvo, MA ;

Guzmán, AM ;

Depix, MS ;

García, P ;

Pérez, C ;

Arrese, M ;

Labarca, JA .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (01) :41-43

[8] The search for a better treatment for recurrent Clostridium difficile disease:: Use of high-dose vancomycin combined with Saccharomyces boulardii [J].

Surawicz, CM ;

McFarland, LV ;

Greenberg, RN ;

Rubin, M ;

Fekety, R ;

Mulligan, ME ;

Garcia, RJ ;

Brandmarker, S ;

Bowen, K ;

Borjal, D ;

Elmer, GW .

CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :1012-1017